Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Levantini, Elena
Item TypeName
Academic Article Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
Academic Article Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice.
Academic Article Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.
Academic Article CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
Academic Article C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence.
Academic Article Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.
Concept CCAAT-Enhancer-Binding Proteins
Concept CCAAT-Enhancer-Binding Protein-alpha
Concept CCAAT-Enhancer-Binding Protein-beta
Academic Article Sox4 is a key oncogenic target in C/EBPa mutant acute myeloid leukemia.
Academic Article CCAAT/enhancer binding protein ß is dispensable for development of lung adenocarcinoma.
Academic Article Acetylation of C/EBPa inhibits its granulopoietic function.
Academic Article Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPa expression.
Academic Article ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPa.
Academic Article Prep1 prevents premature adipogenesis of mesenchymal progenitors.
Search Criteria
  • CCAAT Enhancer Binding Proteins
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.